nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—ADRA1B—vas deferens—testicular cancer	0.0894	0.699	CbGeAlD
Doxazosin—CYP2C19—Ifosfamide—testicular cancer	0.0855	0.246	CbGbCtD
Doxazosin—ABCB1—Dactinomycin—testicular cancer	0.0584	0.168	CbGbCtD
Doxazosin—ABCB1—Vinblastine—testicular cancer	0.0366	0.105	CbGbCtD
Doxazosin—CYP2D6—Vinblastine—testicular cancer	0.0345	0.0994	CbGbCtD
Doxazosin—ABCB1—Cisplatin—testicular cancer	0.0335	0.0967	CbGbCtD
Doxazosin—ABCB1—Etoposide—testicular cancer	0.033	0.095	CbGbCtD
Doxazosin—ABCB1—Doxorubicin—testicular cancer	0.0225	0.0648	CbGbCtD
Doxazosin—ABCB1—Methotrexate—testicular cancer	0.0218	0.0628	CbGbCtD
Doxazosin—CYP2D6—Doxorubicin—testicular cancer	0.0212	0.0611	CbGbCtD
Doxazosin—KCNH7—testis—testicular cancer	0.00871	0.0682	CbGeAlD
Doxazosin—KCNH2—seminal vesicle—testicular cancer	0.00366	0.0287	CbGeAlD
Doxazosin—ADRA2A—seminal vesicle—testicular cancer	0.00288	0.0226	CbGeAlD
Doxazosin—KCNH2—female gonad—testicular cancer	0.00215	0.0168	CbGeAlD
Doxazosin—ADRA2A—gonad—testicular cancer	0.00208	0.0163	CbGeAlD
Doxazosin—ORM1—lymph node—testicular cancer	0.00205	0.0161	CbGeAlD
Doxazosin—KCNH2—testis—testicular cancer	0.00191	0.0149	CbGeAlD
Doxazosin—ABCB1—embryo—testicular cancer	0.00171	0.0134	CbGeAlD
Doxazosin—ADRA2A—female gonad—testicular cancer	0.00169	0.0132	CbGeAlD
Doxazosin—ABCB1—seminal vesicle—testicular cancer	0.00161	0.0126	CbGeAlD
Doxazosin—ADRA2A—testis—testicular cancer	0.0015	0.0117	CbGeAlD
Doxazosin—KCNH2—lymph node—testicular cancer	0.00138	0.0108	CbGeAlD
Doxazosin—CYP2D6—female gonad—testicular cancer	0.00131	0.0103	CbGeAlD
Doxazosin—CYP2D6—testis—testicular cancer	0.00116	0.0091	CbGeAlD
Doxazosin—ABCB1—gonad—testicular cancer	0.00116	0.00908	CbGeAlD
Doxazosin—ADRA2A—lymph node—testicular cancer	0.00109	0.00852	CbGeAlD
Doxazosin—ABCB1—female gonad—testicular cancer	0.000944	0.00738	CbGeAlD
Doxazosin—ABCB1—testis—testicular cancer	0.000837	0.00655	CbGeAlD
Doxazosin—ABCB1—lymph node—testicular cancer	0.000607	0.00475	CbGeAlD
Doxazosin—Conjunctivitis—Epirubicin—testicular cancer	0.000389	0.00074	CcSEcCtD
Doxazosin—Urinary tract infection—Epirubicin—testicular cancer	0.000389	0.00074	CcSEcCtD
Doxazosin—Dysuria—Doxorubicin—testicular cancer	0.000388	0.000739	CcSEcCtD
Doxazosin—Neutropenia—Doxorubicin—testicular cancer	0.000388	0.000739	CcSEcCtD
Doxazosin—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000386	0.000734	CcSEcCtD
Doxazosin—Hepatitis—Methotrexate—testicular cancer	0.000384	0.00073	CcSEcCtD
Doxazosin—Sweating—Epirubicin—testicular cancer	0.000383	0.00073	CcSEcCtD
Doxazosin—Pollakiuria—Doxorubicin—testicular cancer	0.000383	0.00073	CcSEcCtD
Doxazosin—Haematuria—Epirubicin—testicular cancer	0.000381	0.000726	CcSEcCtD
Doxazosin—Dizziness—Ifosfamide—testicular cancer	0.000381	0.000725	CcSEcCtD
Doxazosin—Pharyngitis—Methotrexate—testicular cancer	0.000381	0.000725	CcSEcCtD
Doxazosin—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000379	0.000721	CcSEcCtD
Doxazosin—Weight increased—Doxorubicin—testicular cancer	0.000378	0.000719	CcSEcCtD
Doxazosin—Epistaxis—Epirubicin—testicular cancer	0.000377	0.000718	CcSEcCtD
Doxazosin—Weight decreased—Doxorubicin—testicular cancer	0.000375	0.000715	CcSEcCtD
Doxazosin—Sinusitis—Epirubicin—testicular cancer	0.000375	0.000714	CcSEcCtD
Doxazosin—Feeling abnormal—Etoposide—testicular cancer	0.000375	0.000714	CcSEcCtD
Doxazosin—Hyperglycaemia—Doxorubicin—testicular cancer	0.000374	0.000713	CcSEcCtD
Doxazosin—Nausea—Dactinomycin—testicular cancer	0.000373	0.000711	CcSEcCtD
Doxazosin—Pneumonia—Doxorubicin—testicular cancer	0.000372	0.000709	CcSEcCtD
Doxazosin—Gastrointestinal pain—Etoposide—testicular cancer	0.000372	0.000708	CcSEcCtD
Doxazosin—Drowsiness—Doxorubicin—testicular cancer	0.00037	0.000704	CcSEcCtD
Doxazosin—Visual impairment—Methotrexate—testicular cancer	0.00037	0.000704	CcSEcCtD
Doxazosin—Vomiting—Ifosfamide—testicular cancer	0.000366	0.000697	CcSEcCtD
Doxazosin—Hypersensitivity—Cisplatin—testicular cancer	0.000366	0.000697	CcSEcCtD
Doxazosin—Bradycardia—Epirubicin—testicular cancer	0.000365	0.000696	CcSEcCtD
Doxazosin—Rash—Ifosfamide—testicular cancer	0.000363	0.000691	CcSEcCtD
Doxazosin—Dermatitis—Ifosfamide—testicular cancer	0.000363	0.000691	CcSEcCtD
Doxazosin—Urticaria—Etoposide—testicular cancer	0.000361	0.000688	CcSEcCtD
Doxazosin—Jaundice—Doxorubicin—testicular cancer	0.000361	0.000687	CcSEcCtD
Doxazosin—Rhinitis—Epirubicin—testicular cancer	0.00036	0.000685	CcSEcCtD
Doxazosin—Abdominal pain—Etoposide—testicular cancer	0.00036	0.000685	CcSEcCtD
Doxazosin—Body temperature increased—Etoposide—testicular cancer	0.00036	0.000685	CcSEcCtD
Doxazosin—Conjunctivitis—Doxorubicin—testicular cancer	0.00036	0.000685	CcSEcCtD
Doxazosin—Urinary tract infection—Doxorubicin—testicular cancer	0.00036	0.000685	CcSEcCtD
Doxazosin—Hepatitis—Epirubicin—testicular cancer	0.000359	0.000683	CcSEcCtD
Doxazosin—Eye disorder—Methotrexate—testicular cancer	0.000358	0.000682	CcSEcCtD
Doxazosin—Tinnitus—Methotrexate—testicular cancer	0.000358	0.000681	CcSEcCtD
Doxazosin—Hypoaesthesia—Epirubicin—testicular cancer	0.000357	0.00068	CcSEcCtD
Doxazosin—Asthenia—Cisplatin—testicular cancer	0.000356	0.000678	CcSEcCtD
Doxazosin—Pharyngitis—Epirubicin—testicular cancer	0.000356	0.000678	CcSEcCtD
Doxazosin—Sweating—Doxorubicin—testicular cancer	0.000355	0.000675	CcSEcCtD
Doxazosin—Haematuria—Doxorubicin—testicular cancer	0.000353	0.000672	CcSEcCtD
Doxazosin—Epistaxis—Doxorubicin—testicular cancer	0.000349	0.000664	CcSEcCtD
Doxazosin—Sinusitis—Doxorubicin—testicular cancer	0.000347	0.000661	CcSEcCtD
Doxazosin—Visual impairment—Epirubicin—testicular cancer	0.000346	0.000659	CcSEcCtD
Doxazosin—Chills—Methotrexate—testicular cancer	0.000344	0.000655	CcSEcCtD
Doxazosin—Nausea—Ifosfamide—testicular cancer	0.000342	0.000651	CcSEcCtD
Doxazosin—Diarrhoea—Cisplatin—testicular cancer	0.00034	0.000647	CcSEcCtD
Doxazosin—Alopecia—Methotrexate—testicular cancer	0.000339	0.000645	CcSEcCtD
Doxazosin—Bradycardia—Doxorubicin—testicular cancer	0.000338	0.000644	CcSEcCtD
Doxazosin—Mental disorder—Methotrexate—testicular cancer	0.000336	0.00064	CcSEcCtD
Doxazosin—Eye disorder—Epirubicin—testicular cancer	0.000335	0.000639	CcSEcCtD
Doxazosin—Hypersensitivity—Etoposide—testicular cancer	0.000335	0.000638	CcSEcCtD
Doxazosin—Tinnitus—Epirubicin—testicular cancer	0.000335	0.000637	CcSEcCtD
Doxazosin—Malnutrition—Methotrexate—testicular cancer	0.000334	0.000636	CcSEcCtD
Doxazosin—Flushing—Epirubicin—testicular cancer	0.000333	0.000634	CcSEcCtD
Doxazosin—Rhinitis—Doxorubicin—testicular cancer	0.000333	0.000634	CcSEcCtD
Doxazosin—Hepatitis—Doxorubicin—testicular cancer	0.000332	0.000632	CcSEcCtD
Doxazosin—Hypoaesthesia—Doxorubicin—testicular cancer	0.00033	0.000629	CcSEcCtD
Doxazosin—Pharyngitis—Doxorubicin—testicular cancer	0.00033	0.000628	CcSEcCtD
Doxazosin—Dysgeusia—Methotrexate—testicular cancer	0.000327	0.000623	CcSEcCtD
Doxazosin—Asthenia—Etoposide—testicular cancer	0.000326	0.000621	CcSEcCtD
Doxazosin—Back pain—Methotrexate—testicular cancer	0.000323	0.000615	CcSEcCtD
Doxazosin—Chills—Epirubicin—testicular cancer	0.000322	0.000613	CcSEcCtD
Doxazosin—Pruritus—Etoposide—testicular cancer	0.000322	0.000613	CcSEcCtD
Doxazosin—Arrhythmia—Epirubicin—testicular cancer	0.000321	0.000611	CcSEcCtD
Doxazosin—Visual impairment—Doxorubicin—testicular cancer	0.00032	0.000609	CcSEcCtD
Doxazosin—Alopecia—Epirubicin—testicular cancer	0.000317	0.000604	CcSEcCtD
Doxazosin—Vomiting—Cisplatin—testicular cancer	0.000316	0.000601	CcSEcCtD
Doxazosin—Vision blurred—Methotrexate—testicular cancer	0.000315	0.000599	CcSEcCtD
Doxazosin—Mental disorder—Epirubicin—testicular cancer	0.000314	0.000599	CcSEcCtD
Doxazosin—Rash—Cisplatin—testicular cancer	0.000313	0.000596	CcSEcCtD
Doxazosin—Dermatitis—Cisplatin—testicular cancer	0.000313	0.000596	CcSEcCtD
Doxazosin—Malnutrition—Epirubicin—testicular cancer	0.000312	0.000595	CcSEcCtD
Doxazosin—Diarrhoea—Etoposide—testicular cancer	0.000311	0.000593	CcSEcCtD
Doxazosin—Eye disorder—Doxorubicin—testicular cancer	0.00031	0.000591	CcSEcCtD
Doxazosin—Ill-defined disorder—Methotrexate—testicular cancer	0.00031	0.00059	CcSEcCtD
Doxazosin—Tinnitus—Doxorubicin—testicular cancer	0.00031	0.00059	CcSEcCtD
Doxazosin—Flushing—Doxorubicin—testicular cancer	0.000308	0.000587	CcSEcCtD
Doxazosin—Flatulence—Epirubicin—testicular cancer	0.000308	0.000586	CcSEcCtD
Doxazosin—Tension—Epirubicin—testicular cancer	0.000307	0.000584	CcSEcCtD
Doxazosin—Dysgeusia—Epirubicin—testicular cancer	0.000306	0.000583	CcSEcCtD
Doxazosin—Nervousness—Epirubicin—testicular cancer	0.000303	0.000578	CcSEcCtD
Doxazosin—Back pain—Epirubicin—testicular cancer	0.000302	0.000575	CcSEcCtD
Doxazosin—Malaise—Methotrexate—testicular cancer	0.000301	0.000573	CcSEcCtD
Doxazosin—Dizziness—Etoposide—testicular cancer	0.000301	0.000573	CcSEcCtD
Doxazosin—Muscle spasms—Epirubicin—testicular cancer	0.0003	0.000572	CcSEcCtD
Doxazosin—Vertigo—Methotrexate—testicular cancer	0.0003	0.000571	CcSEcCtD
Doxazosin—Leukopenia—Methotrexate—testicular cancer	0.000299	0.000569	CcSEcCtD
Doxazosin—Chills—Doxorubicin—testicular cancer	0.000298	0.000567	CcSEcCtD
Doxazosin—Arrhythmia—Doxorubicin—testicular cancer	0.000297	0.000565	CcSEcCtD
Doxazosin—Nausea—Cisplatin—testicular cancer	0.000295	0.000562	CcSEcCtD
Doxazosin—Vision blurred—Epirubicin—testicular cancer	0.000294	0.000561	CcSEcCtD
Doxazosin—Alopecia—Doxorubicin—testicular cancer	0.000293	0.000559	CcSEcCtD
Doxazosin—Cough—Methotrexate—testicular cancer	0.000291	0.000555	CcSEcCtD
Doxazosin—Mental disorder—Doxorubicin—testicular cancer	0.000291	0.000554	CcSEcCtD
Doxazosin—Ill-defined disorder—Epirubicin—testicular cancer	0.00029	0.000552	CcSEcCtD
Doxazosin—Convulsion—Methotrexate—testicular cancer	0.000289	0.000551	CcSEcCtD
Doxazosin—Vomiting—Etoposide—testicular cancer	0.000289	0.000551	CcSEcCtD
Doxazosin—Malnutrition—Doxorubicin—testicular cancer	0.000289	0.00055	CcSEcCtD
Doxazosin—Agitation—Epirubicin—testicular cancer	0.000287	0.000547	CcSEcCtD
Doxazosin—Rash—Etoposide—testicular cancer	0.000287	0.000546	CcSEcCtD
Doxazosin—Dermatitis—Etoposide—testicular cancer	0.000287	0.000546	CcSEcCtD
Doxazosin—Headache—Etoposide—testicular cancer	0.000285	0.000543	CcSEcCtD
Doxazosin—Flatulence—Doxorubicin—testicular cancer	0.000285	0.000542	CcSEcCtD
Doxazosin—Myalgia—Methotrexate—testicular cancer	0.000284	0.000541	CcSEcCtD
Doxazosin—Chest pain—Methotrexate—testicular cancer	0.000284	0.000541	CcSEcCtD
Doxazosin—Arthralgia—Methotrexate—testicular cancer	0.000284	0.000541	CcSEcCtD
Doxazosin—Tension—Doxorubicin—testicular cancer	0.000284	0.00054	CcSEcCtD
Doxazosin—Dysgeusia—Doxorubicin—testicular cancer	0.000283	0.000539	CcSEcCtD
Doxazosin—Malaise—Epirubicin—testicular cancer	0.000282	0.000537	CcSEcCtD
Doxazosin—Discomfort—Methotrexate—testicular cancer	0.000281	0.000535	CcSEcCtD
Doxazosin—Nervousness—Doxorubicin—testicular cancer	0.000281	0.000535	CcSEcCtD
Doxazosin—Vertigo—Epirubicin—testicular cancer	0.000281	0.000535	CcSEcCtD
Doxazosin—Syncope—Epirubicin—testicular cancer	0.00028	0.000534	CcSEcCtD
Doxazosin—Leukopenia—Epirubicin—testicular cancer	0.00028	0.000533	CcSEcCtD
Doxazosin—Back pain—Doxorubicin—testicular cancer	0.00028	0.000532	CcSEcCtD
Doxazosin—Muscle spasms—Doxorubicin—testicular cancer	0.000278	0.000529	CcSEcCtD
Doxazosin—Palpitations—Epirubicin—testicular cancer	0.000276	0.000526	CcSEcCtD
Doxazosin—Confusional state—Methotrexate—testicular cancer	0.000275	0.000523	CcSEcCtD
Doxazosin—Loss of consciousness—Epirubicin—testicular cancer	0.000275	0.000523	CcSEcCtD
Doxazosin—Cough—Epirubicin—testicular cancer	0.000273	0.000519	CcSEcCtD
Doxazosin—Vision blurred—Doxorubicin—testicular cancer	0.000272	0.000519	CcSEcCtD
Doxazosin—Convulsion—Epirubicin—testicular cancer	0.000271	0.000515	CcSEcCtD
Doxazosin—Infection—Methotrexate—testicular cancer	0.000271	0.000515	CcSEcCtD
Doxazosin—Nausea—Etoposide—testicular cancer	0.00027	0.000515	CcSEcCtD
Doxazosin—Hypertension—Epirubicin—testicular cancer	0.00027	0.000514	CcSEcCtD
Doxazosin—Ill-defined disorder—Doxorubicin—testicular cancer	0.000268	0.000511	CcSEcCtD
Doxazosin—Thrombocytopenia—Methotrexate—testicular cancer	0.000267	0.000508	CcSEcCtD
Doxazosin—Chest pain—Epirubicin—testicular cancer	0.000266	0.000506	CcSEcCtD
Doxazosin—Myalgia—Epirubicin—testicular cancer	0.000266	0.000506	CcSEcCtD
Doxazosin—Arthralgia—Epirubicin—testicular cancer	0.000266	0.000506	CcSEcCtD
Doxazosin—Agitation—Doxorubicin—testicular cancer	0.000266	0.000506	CcSEcCtD
Doxazosin—Anxiety—Epirubicin—testicular cancer	0.000265	0.000505	CcSEcCtD
Doxazosin—Skin disorder—Methotrexate—testicular cancer	0.000265	0.000504	CcSEcCtD
Doxazosin—Hyperhidrosis—Methotrexate—testicular cancer	0.000263	0.000502	CcSEcCtD
Doxazosin—Discomfort—Epirubicin—testicular cancer	0.000263	0.0005	CcSEcCtD
Doxazosin—Malaise—Doxorubicin—testicular cancer	0.000261	0.000496	CcSEcCtD
Doxazosin—Dry mouth—Epirubicin—testicular cancer	0.00026	0.000495	CcSEcCtD
Doxazosin—Vertigo—Doxorubicin—testicular cancer	0.00026	0.000495	CcSEcCtD
Doxazosin—Anorexia—Methotrexate—testicular cancer	0.00026	0.000495	CcSEcCtD
Doxazosin—Syncope—Doxorubicin—testicular cancer	0.000259	0.000494	CcSEcCtD
Doxazosin—Leukopenia—Doxorubicin—testicular cancer	0.000259	0.000493	CcSEcCtD
Doxazosin—Confusional state—Epirubicin—testicular cancer	0.000257	0.00049	CcSEcCtD
Doxazosin—Palpitations—Doxorubicin—testicular cancer	0.000255	0.000486	CcSEcCtD
Doxazosin—Oedema—Epirubicin—testicular cancer	0.000255	0.000486	CcSEcCtD
Doxazosin—Hypotension—Methotrexate—testicular cancer	0.000255	0.000485	CcSEcCtD
Doxazosin—Loss of consciousness—Doxorubicin—testicular cancer	0.000254	0.000484	CcSEcCtD
Doxazosin—Infection—Epirubicin—testicular cancer	0.000253	0.000482	CcSEcCtD
Doxazosin—Cough—Doxorubicin—testicular cancer	0.000252	0.00048	CcSEcCtD
Doxazosin—Shock—Epirubicin—testicular cancer	0.000251	0.000478	CcSEcCtD
Doxazosin—Convulsion—Doxorubicin—testicular cancer	0.00025	0.000477	CcSEcCtD
Doxazosin—Thrombocytopenia—Epirubicin—testicular cancer	0.00025	0.000475	CcSEcCtD
Doxazosin—Hypertension—Doxorubicin—testicular cancer	0.00025	0.000475	CcSEcCtD
Doxazosin—Tachycardia—Epirubicin—testicular cancer	0.000249	0.000474	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000248	0.000473	CcSEcCtD
Doxazosin—Skin disorder—Epirubicin—testicular cancer	0.000248	0.000472	CcSEcCtD
Doxazosin—Hyperhidrosis—Epirubicin—testicular cancer	0.000247	0.000469	CcSEcCtD
Doxazosin—Insomnia—Methotrexate—testicular cancer	0.000246	0.000469	CcSEcCtD
Doxazosin—Chest pain—Doxorubicin—testicular cancer	0.000246	0.000469	CcSEcCtD
Doxazosin—Arthralgia—Doxorubicin—testicular cancer	0.000246	0.000469	CcSEcCtD
Doxazosin—Myalgia—Doxorubicin—testicular cancer	0.000246	0.000469	CcSEcCtD
Doxazosin—Anxiety—Doxorubicin—testicular cancer	0.000245	0.000467	CcSEcCtD
Doxazosin—Paraesthesia—Methotrexate—testicular cancer	0.000245	0.000466	CcSEcCtD
Doxazosin—Discomfort—Doxorubicin—testicular cancer	0.000243	0.000463	CcSEcCtD
Doxazosin—Anorexia—Epirubicin—testicular cancer	0.000243	0.000463	CcSEcCtD
Doxazosin—Dyspnoea—Methotrexate—testicular cancer	0.000243	0.000463	CcSEcCtD
Doxazosin—Somnolence—Methotrexate—testicular cancer	0.000242	0.000461	CcSEcCtD
Doxazosin—Dry mouth—Doxorubicin—testicular cancer	0.000241	0.000458	CcSEcCtD
Doxazosin—Dyspepsia—Methotrexate—testicular cancer	0.00024	0.000457	CcSEcCtD
Doxazosin—Hypotension—Epirubicin—testicular cancer	0.000238	0.000454	CcSEcCtD
Doxazosin—Confusional state—Doxorubicin—testicular cancer	0.000238	0.000453	CcSEcCtD
Doxazosin—Decreased appetite—Methotrexate—testicular cancer	0.000237	0.000451	CcSEcCtD
Doxazosin—Oedema—Doxorubicin—testicular cancer	0.000236	0.000449	CcSEcCtD
Doxazosin—Fatigue—Methotrexate—testicular cancer	0.000235	0.000447	CcSEcCtD
Doxazosin—Infection—Doxorubicin—testicular cancer	0.000234	0.000446	CcSEcCtD
Doxazosin—Pain—Methotrexate—testicular cancer	0.000233	0.000444	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000232	0.000442	CcSEcCtD
Doxazosin—Shock—Doxorubicin—testicular cancer	0.000232	0.000442	CcSEcCtD
Doxazosin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000231	0.00044	CcSEcCtD
Doxazosin—Insomnia—Epirubicin—testicular cancer	0.000231	0.000439	CcSEcCtD
Doxazosin—Tachycardia—Doxorubicin—testicular cancer	0.00023	0.000438	CcSEcCtD
Doxazosin—Skin disorder—Doxorubicin—testicular cancer	0.000229	0.000436	CcSEcCtD
Doxazosin—Paraesthesia—Epirubicin—testicular cancer	0.000229	0.000436	CcSEcCtD
Doxazosin—Hyperhidrosis—Doxorubicin—testicular cancer	0.000228	0.000434	CcSEcCtD
Doxazosin—Dyspnoea—Epirubicin—testicular cancer	0.000227	0.000433	CcSEcCtD
Doxazosin—Somnolence—Epirubicin—testicular cancer	0.000227	0.000432	CcSEcCtD
Doxazosin—Anorexia—Doxorubicin—testicular cancer	0.000225	0.000428	CcSEcCtD
Doxazosin—Feeling abnormal—Methotrexate—testicular cancer	0.000225	0.000428	CcSEcCtD
Doxazosin—Dyspepsia—Epirubicin—testicular cancer	0.000224	0.000427	CcSEcCtD
Doxazosin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000223	0.000424	CcSEcCtD
Doxazosin—Decreased appetite—Epirubicin—testicular cancer	0.000222	0.000422	CcSEcCtD
Doxazosin—Hypotension—Doxorubicin—testicular cancer	0.00022	0.00042	CcSEcCtD
Doxazosin—Fatigue—Epirubicin—testicular cancer	0.00022	0.000419	CcSEcCtD
Doxazosin—Pain—Epirubicin—testicular cancer	0.000218	0.000415	CcSEcCtD
Doxazosin—Constipation—Epirubicin—testicular cancer	0.000218	0.000415	CcSEcCtD
Doxazosin—Urticaria—Methotrexate—testicular cancer	0.000216	0.000412	CcSEcCtD
Doxazosin—Body temperature increased—Methotrexate—testicular cancer	0.000215	0.00041	CcSEcCtD
Doxazosin—Abdominal pain—Methotrexate—testicular cancer	0.000215	0.00041	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000215	0.000409	CcSEcCtD
Doxazosin—Insomnia—Doxorubicin—testicular cancer	0.000213	0.000406	CcSEcCtD
Doxazosin—Paraesthesia—Doxorubicin—testicular cancer	0.000212	0.000403	CcSEcCtD
Doxazosin—Dyspnoea—Doxorubicin—testicular cancer	0.00021	0.000401	CcSEcCtD
Doxazosin—Feeling abnormal—Epirubicin—testicular cancer	0.00021	0.0004	CcSEcCtD
Doxazosin—Somnolence—Doxorubicin—testicular cancer	0.00021	0.000399	CcSEcCtD
Doxazosin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000209	0.000397	CcSEcCtD
Doxazosin—Dyspepsia—Doxorubicin—testicular cancer	0.000208	0.000395	CcSEcCtD
Doxazosin—Decreased appetite—Doxorubicin—testicular cancer	0.000205	0.000391	CcSEcCtD
Doxazosin—Fatigue—Doxorubicin—testicular cancer	0.000203	0.000387	CcSEcCtD
Doxazosin—Urticaria—Epirubicin—testicular cancer	0.000203	0.000386	CcSEcCtD
Doxazosin—Constipation—Doxorubicin—testicular cancer	0.000202	0.000384	CcSEcCtD
Doxazosin—Pain—Doxorubicin—testicular cancer	0.000202	0.000384	CcSEcCtD
Doxazosin—Abdominal pain—Epirubicin—testicular cancer	0.000202	0.000384	CcSEcCtD
Doxazosin—Body temperature increased—Epirubicin—testicular cancer	0.000202	0.000384	CcSEcCtD
Doxazosin—Hypersensitivity—Methotrexate—testicular cancer	0.000201	0.000382	CcSEcCtD
Doxazosin—Asthenia—Methotrexate—testicular cancer	0.000196	0.000372	CcSEcCtD
Doxazosin—Feeling abnormal—Doxorubicin—testicular cancer	0.000194	0.00037	CcSEcCtD
Doxazosin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000193	0.000367	CcSEcCtD
Doxazosin—Pruritus—Methotrexate—testicular cancer	0.000193	0.000367	CcSEcCtD
Doxazosin—Hypersensitivity—Epirubicin—testicular cancer	0.000188	0.000358	CcSEcCtD
Doxazosin—Urticaria—Doxorubicin—testicular cancer	0.000187	0.000357	CcSEcCtD
Doxazosin—Body temperature increased—Doxorubicin—testicular cancer	0.000187	0.000355	CcSEcCtD
Doxazosin—Abdominal pain—Doxorubicin—testicular cancer	0.000187	0.000355	CcSEcCtD
Doxazosin—Diarrhoea—Methotrexate—testicular cancer	0.000186	0.000355	CcSEcCtD
Doxazosin—Asthenia—Epirubicin—testicular cancer	0.000183	0.000348	CcSEcCtD
Doxazosin—Pruritus—Epirubicin—testicular cancer	0.00018	0.000344	CcSEcCtD
Doxazosin—Dizziness—Methotrexate—testicular cancer	0.00018	0.000343	CcSEcCtD
Doxazosin—Diarrhoea—Epirubicin—testicular cancer	0.000174	0.000332	CcSEcCtD
Doxazosin—Hypersensitivity—Doxorubicin—testicular cancer	0.000174	0.000331	CcSEcCtD
Doxazosin—Vomiting—Methotrexate—testicular cancer	0.000173	0.00033	CcSEcCtD
Doxazosin—Rash—Methotrexate—testicular cancer	0.000172	0.000327	CcSEcCtD
Doxazosin—Dermatitis—Methotrexate—testicular cancer	0.000172	0.000327	CcSEcCtD
Doxazosin—Headache—Methotrexate—testicular cancer	0.000171	0.000325	CcSEcCtD
Doxazosin—Asthenia—Doxorubicin—testicular cancer	0.000169	0.000322	CcSEcCtD
Doxazosin—Dizziness—Epirubicin—testicular cancer	0.000169	0.000321	CcSEcCtD
Doxazosin—Pruritus—Doxorubicin—testicular cancer	0.000167	0.000318	CcSEcCtD
Doxazosin—Vomiting—Epirubicin—testicular cancer	0.000162	0.000309	CcSEcCtD
Doxazosin—Nausea—Methotrexate—testicular cancer	0.000162	0.000308	CcSEcCtD
Doxazosin—Diarrhoea—Doxorubicin—testicular cancer	0.000161	0.000307	CcSEcCtD
Doxazosin—Rash—Epirubicin—testicular cancer	0.000161	0.000306	CcSEcCtD
Doxazosin—Dermatitis—Epirubicin—testicular cancer	0.000161	0.000306	CcSEcCtD
Doxazosin—Headache—Epirubicin—testicular cancer	0.00016	0.000304	CcSEcCtD
Doxazosin—Dizziness—Doxorubicin—testicular cancer	0.000156	0.000297	CcSEcCtD
Doxazosin—Nausea—Epirubicin—testicular cancer	0.000151	0.000288	CcSEcCtD
Doxazosin—Vomiting—Doxorubicin—testicular cancer	0.00015	0.000286	CcSEcCtD
Doxazosin—Rash—Doxorubicin—testicular cancer	0.000149	0.000283	CcSEcCtD
Doxazosin—Dermatitis—Doxorubicin—testicular cancer	0.000149	0.000283	CcSEcCtD
Doxazosin—Headache—Doxorubicin—testicular cancer	0.000148	0.000281	CcSEcCtD
Doxazosin—Nausea—Doxorubicin—testicular cancer	0.00014	0.000267	CcSEcCtD
